Jump to navigation
By Peter Hotez
This post is part of the #ProtectingKids blog series. Read the whole series here.
Today, representatives at the Sixty-fifth World Health Assembly gave their support to a new Global Vaccine Action Plan (GVAP). WHA endorsement of the GVAP marks a major milestone towards universal access to immunization.
This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.